News
City2Surf 2020
Join in the fun of the virtual event, and together we can run over melanoma!
Top melanoma experts from MIA
Melanoma Institute Australia features prominently in the latest ‘Expertise in Melanoma’ world rankings, released by Expertscape.
Melanoma Supportive Care Needs research study.
Participate in our online survey and help us understand the support needs of melanoma patients and carers.
New data reveals long-term benefit of adjuvant therapy for Stage III melanoma.
New online melanoma risk calculators critical to saving lives
Clinicians and their patients now have access to three online risk calculators developed by researchers at Melanoma Institute Australia.
Professor Richard Scolyer receives University of Sydney Alumni Award.
MIA's Co-Medical Director Professor Richard Scolyer has received The University of Sydney Alumni Award for International Achievement.
Uniting together despite the distance
More than 120 MIA clinicians, researchers and staff came together online to share research highlights.
Professor Richard Scolyer recognised in The Pathologist's 2020 Power List.
For the 2nd consecutive year, MIA's Co-Medical Director Professor Richard Scolyer has been selected in the top 100 best, brightest, and most powerful advocates of pathology by The Pathologist.
Important Update: Masks required at Poche Centre
As of Monday 27th July all patients and carers/family members coming into The Poche Centre will be required to bring their own mask.
A Critical Nexus:The Clinician and the Researcher.
In a recent issue of Cancer Cell journal, Prof Georgina Long AO and Prof Richard Scolyer discuss the challenge of bringing together clinical work and scientific research to underpin successful cancer research.
Founding father recognised for outstanding cancer care
Professor William McCarthy AM has been awarded the Tom Reeve Award for Outstanding Contributions to Cancer Care.
Melanoma researchers shine at the State's premier cancer awards ceremony
Leading researchers from MIA have been acknowledged with three prestigious awards for excellence in melanoma research.
Enhancing melanoma treatment response through gut bacteria
New research shows that patients who are more likely to respond to immunotherapy treatment have a greater diversity in their gut bacteria.
Melanoma March is just around the corner!
2018 will be bigger than ever, and a little bit different.
Comparing melanoma risk in similar populations across different latitudes
MIA's epidemiologist explains her new research on how country of residence should be considered when identifying melanoma risk.
Congratulations to our Conjoint Medical Directors
Congratulations to our Conjoint Medical Directors, Professor Georgina Long and Professor Richard Scolyer, who have today been announced as Fellows of the Australian Academy of Health and Medical Sciences.
What causes melanoma in 90% of young Australians?
New research shows potentially deadly UV damage can appear decades earlier than you think.
Early lymph node check is saving lives in melanoma patients
Early lymph node check is saving lives in melanoma patients
Congratulations to Associate Professor Anne Cust
We are pleased to announce that A/Prof Anne Cust is the new President of the Australasian Epidemiological Association.
Smoking linked to increased risk of melanoma spreading
New research has shown that melanoma patients who smoke have an increased risk of their disease progressing compared to patients who do not smoke.
Research boost to improve outcomes for melanoma patients
More than $3.5 million in competitive funding grants have been awarded to MIA's researchers.
Highlights in melanoma research from ESMO
The ESMO conference provided a platform for announcing a number of key melanoma research findings - including practice-changing research from MIA.
Australian researchers stopping melanoma in its tracks
Australian researchers have successfully trialled a combination of new treatments to prevent melanoma from spreading to distant organs.
Virus-antibody combo shows promise for treating advanced melanoma
A new treatment that combines an antibody with a cancer-killing virus improves outcomes for patients with advanced melanoma, an international clinical trial has shown.
It's time to outlaw sunburn on reality TV shows - enough is enough
It feels like groundhog day - another reality TV show, another batch of blatantly sunburnt contestants.
Identifying markers for optimal response
Wouldn’t it be great if your doctor could know if you would respond to treatment before you even had it?
Global Melanoma Research Report - July
In our latest research update we showcase research in survival estimates, uncover biomarkers, and reveal practice-changing research in surgery and medical oncology.
A day in the life of... Sarah Lane
Senior Clinical Trial Coordinators, like Sarah Lane, support melanoma patients throughout the clinical trial process.
Differentiating moles from melanoma
Melanomas are often hard to differentiate from moles. But new technology is helping to improve accuracy of diagnosis.
Introducing SunSense Sunscreen
We are excited to announce that SunSense will proudly be an official supporter of Melanoma Institute Australia. SunSense is an Australian, family owned business.